logo-loader
VolitionRx

VolitionRX hosts Capital Markets Day at the NYSE

VolitionRx (NYSE AMERICAN:VNRX) CEO Cameron Reynolds tells Proactive Investors the life sciences company has organized a Capital Markets Day to bring together shareholders, company executives and analysts at the New York Stock Exchange.

The company plans to offer updates of results, ongoing projects and of plans for potential new paths to revenue, including trials in diagnosing lung cancer.

Quick facts: VolitionRx

Price: $4.18

Market: NYSEMKT
Market Cap: $171.76 m
Follow

Watch

VolitionRx well positioned as it enters Q2 after strengthening balance sheet

Cameron Reynolds, chief executive of VolitionRx Limited (NYSE AMERICAN:VNRX), tells Proactive London's Andrew Scott they're in a good place after again strengthening the balance sheet in recent weeks with a further $5 million in warrants exercised for cash. ''Total cash in hand that gives...

on 9/5/19

2 min read

;